Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Kehoe

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
Diseases (Basel, Switzerland)|September 27, 2024
Survival Trends for Uterine Sarcomas from a Tertiary Center: The Oxford ExperienceAakriti Aggarwal, Federico Ferrari, Andreas Zouridis, et al.
The Cochrane Database of Systematic Reviews|November 20, 2014
Epidermal growth factor receptor blockers for the treatment of ovarian cancerKrishnayan Haldar, Kezia Gaitskell, Andrew Bryant, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 4, 2012
The role of frozen sections in gynaecological oncology: survey of practice in the United KingdomRaji Ganesan, Laurance J R Brown, Sean Kehoe, et al.
The Cochrane Database of Systematic Reviews|November 6, 2019
Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancerSarah L Coleridge, Andrew Bryant, Thomas J Lyons, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|July 26, 2017
Predictive value of the age-adjusted Charlston co-morbidity index on peri-operative complications, adjuvant chemotherapy usage and survival in patients undergoing debulking surgery after neo-adjuvant chemotherapy for advanced epithelial ovarian cancerAndrew Phillips, Kavita Singh, Rachel Pounds, et al.
Scientific Reports|September 4, 2021
Aberrant activation of the Hedgehog signalling pathway in squamous cell carcinoma of the vulva as a potential target for cancer therapyJason K W Yap, Khalil Uddin, Rachel Pounds, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|February 11, 2018
Effect of blue dye guided lymph channel ligation on the surgical morbidity of groin lymphadenectomy for vulval cancer: a feasibility studyRasiah Bharathan, Kavitha Madhuri, Andrew Fish, et al.
Gynecologic Oncology|January 29, 2020
The role of preoperative computerized tomography (CT) scan of the pelvis and groin in the management of clinically early staged vulva squamous cell carcinomaRachel Pounds, Danielle O'Neill, Kamana Subba, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2007
Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptorJoanne Morrison, Simon S Briggs, Nicola Green, et al.
Gynecologic Oncology|September 14, 2016
Over-expression of DNMT3A predicts the risk of recurrent vulvar squamous cell carcinomasSarah Leonard, Merlin Pereira, Richard Fox, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
Diseases (Basel, Switzerland)|September 27, 2024
Survival Trends for Uterine Sarcomas from a Tertiary Center: The Oxford ExperienceAakriti Aggarwal, Federico Ferrari, Andreas Zouridis, et al.
The Cochrane Database of Systematic Reviews|November 20, 2014
Epidermal growth factor receptor blockers for the treatment of ovarian cancerKrishnayan Haldar, Kezia Gaitskell, Andrew Bryant, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 4, 2012
The role of frozen sections in gynaecological oncology: survey of practice in the United KingdomRaji Ganesan, Laurance J R Brown, Sean Kehoe, et al.
The Cochrane Database of Systematic Reviews|November 6, 2019
Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancerSarah L Coleridge, Andrew Bryant, Thomas J Lyons, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|July 26, 2017
Predictive value of the age-adjusted Charlston co-morbidity index on peri-operative complications, adjuvant chemotherapy usage and survival in patients undergoing debulking surgery after neo-adjuvant chemotherapy for advanced epithelial ovarian cancerAndrew Phillips, Kavita Singh, Rachel Pounds, et al.
Scientific Reports|September 4, 2021
Aberrant activation of the Hedgehog signalling pathway in squamous cell carcinoma of the vulva as a potential target for cancer therapyJason K W Yap, Khalil Uddin, Rachel Pounds, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|February 11, 2018
Effect of blue dye guided lymph channel ligation on the surgical morbidity of groin lymphadenectomy for vulval cancer: a feasibility studyRasiah Bharathan, Kavitha Madhuri, Andrew Fish, et al.
Gynecologic Oncology|January 29, 2020
The role of preoperative computerized tomography (CT) scan of the pelvis and groin in the management of clinically early staged vulva squamous cell carcinomaRachel Pounds, Danielle O'Neill, Kamana Subba, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2007
Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptorJoanne Morrison, Simon S Briggs, Nicola Green, et al.
Gynecologic Oncology|September 14, 2016
Over-expression of DNMT3A predicts the risk of recurrent vulvar squamous cell carcinomasSarah Leonard, Merlin Pereira, Richard Fox, et al.
Pageof 10